17402d95dab5965bca2b1b.pdf For Immediate Release 5 October 2015 Copper Development Corporation ('CDC' or 'the Company')


Arrangements in connection with the Name Change


Further to the announcement released earlier today concerning the results of the General Meeting, the Company advises that the new ISIN issued in conjunction with the name change to Life Science Developments Limited will be as follows: VGG7255F1062.


For further information please contact:


Copper Development Corporation +44 (0) 1624 639 396 Mitch Alland, Executive Chairman & Chief Executive Officer

Denham Eke, Chief Financial Officer


Beaumont Cornish Limited (Nominated Adviser and Broker) +44 (0) 207 628 3396 Roland Cornish and James Biddle
distributed by